bromocriptine has been researched along with guanfacine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Klijn, JG; Lamberts, SW; Stefanko, SZ; van Vroonhoven, CC | 1 |
Aarts, E; D'Esposito, M; Gratton, C; Silver, MA; Wallace, DL; Yousef, S | 1 |
1 review(s) available for bromocriptine and guanfacine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for bromocriptine and guanfacine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Growth Hormone; Guanfacine; Guanidines; Humans; Immunochemistry; Middle Aged; Phenylacetates; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1985 |
Cholinergic, But Not Dopaminergic or Noradrenergic, Enhancement Sharpens Visual Spatial Perception in Humans.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Bromocriptine; Cholinesterase Inhibitors; Contrast Sensitivity; Donepezil; Dopamine Agonists; Female; Guanfacine; Humans; Indans; Male; Piperidines; Random Allocation; Visual Cortex | 2017 |